RISANKIZUMAB vs RISEDRONATE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RISANKIZUMAB vs RISEDRONATE: Safety Overview
| Metric | RISANKIZUMAB | RISEDRONATE |
|---|---|---|
| Total FAERS Reports | 2,642 | 6,768 |
| Deaths Reported | 41 | 202 |
| Death Rate | 1.6% | 3.0% |
| Hospitalizations | 439 | 1,825 |
| Average Patient Age | 52.1 yrs | 68.0 yrs |
| % Female Patients | 51.3% | 92.3% |
| FDA Approval Date | N/A | Apr 14, 2000 |
| Manufacturer | AbbVie Inc. | Aurobindo Pharma Limited |
| Route | SUBCUTANEOUS | ORAL |
| Marketing Status | N/A | Discontinued |